A study proposes a radical new approach to the responsible development of innovative products, processes and services by companies and organisations operating in the bioeconomy and related industry sectors.
On April 21st, SynthSys welcomed Jenni Rant and the SAW Training team back to Edinburgh for our second annual training event bringing their innovative approach to teaching science to children using the power of words and pictures.
SynthSys member Dr Matteo Cavaliere and colleagues have recently published a mini-review discussing why the evolutionary resilience of microbial communities should be considered when designing robust biotechnological applications.
Biologics pretty much sweep the leader board for money-making drugs globally. They are also excellent medicines, offering relief for millions of patients with chronic and often life limiting diseases. So what does synthetic biology have to offer this therapeutic success story?
The UK Centre for Mammalian Synthetic Biology had its first Board Meeting on April 3 and 4. Over the two days, the Board heard about progress across all active research work packages as well as several new avenues of research.